Catheterization and Cardiovascular Interventions

Papers
(The H4-Index of Catheterization and Cardiovascular Interventions is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information ‐ Copyright88
Evaluation of the safety and efficacy of the Axiostat® dressing device to achieve radial artery access hemostasis: The R3A study49
Step back to see the complete picture: Complete versus incomplete revascularization of multivessel coronary disease42
Overview of FDA Circulatory System Devices Panel virtual meeting on TriGUARD 3 cerebral embolic protection40
Closing the loop in cath lab communication: Avoiding the tower of babble34
Issue Information ‐ Editorial Board34
Issue Information ‐ Copyright31
Issue Information ‐ Copyright30
27
Transcatheter closure of large postinfarct ventricular septal defect: Initial results of prototype Occlutech® device including the first‐in‐human26
Novel dual guiding catheter technique for kissing balloon inflation in percutaneous coronary intervention for bifurcated chronic total occlusive lesion25
What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity25
Transcatheter edge‐to‐edge repair for mitral regurgitation using PASCAL or MitraClip24
Coil embolization of asymptomatic left gastric artery aneurysm: Case report and literature review24
Sex differences on outcomes following left atrial appendage occlusion in atrial fibrillation: A systematic review and meta‐analysis23
Angiographic predictors of aberrant circumflex artery during cardiac catheterization23
22
Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement22
Less Symptom Improvement in Patients Undergoing TAVI With Concomitant COPD, Atrial Fibrillation and Heart Failure22
Catheter‐based therapy for intermediate or high‐risk pulmonary embolism is associated with lower in‐hospital mortality in patients with cancer: Insights from the National Inpatient Sample21
0.065483808517456